Jan 062016
Talent4Boards - Great Talent builds Great Boards
– USA, MA & PA – Idera Pharmaceuticals, Inc. (IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today announced that Maxine Gowen, Ph.D., joined its Board of Directors, effective January 4, 2016.… => more
Idera Pharmaceuticals appointed Dr Maxine Gowen to its Board of Directors
From:: Idera Pharmaceuticals appointed Dr Maxine Gowen to its Board of Directors
Sorry, the comment form is closed at this time.